[1] Myhre SA, Ruvalcaba RH, Graham CB.A new growth deficiency syndrome[J].Clin Genet, 1981, 20 (1):1-5.
[2] Le Goff C, Mahaut C, Abhyankar A, et al.Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome[J].Nat Genet, 2012, 44 (1):85-88.
[3] Le Goff C, Michot C, Cormier-Daire V.Myhre syndrome[J].Clinical Genetics, 2014, 85 (6):503-513.
[4] Michot C, Le Goff C, Mahaut C, et al.Myhre and LAPS syndromes: clinical and molecular review of 32 patients[J].Eur J Hum Genet, 2014, 22 (11):1272-1277.
[5] Meerschaut I, Beyens A, Steyaert W, et al.Myhre syndrome: A first familial recurrence and broadening of the phenotypic spectrum[J].Am J Med Genet A, 2019,179 (12):2494-2499.
[6] Caputo V, Cianetti L, Niceta M, et al.A restricted spectrum of mutations in the SMAD4 tumor-suppressor gene underlies Myhre syndrome[J].Am J Hum Genet, 2012, 90 (1):161-169.
[7] Whitaker AT, Berthet E, Cantu A, et al.Smad4 regulates growth plate matrix production and chondrocyte polarity[J].Biol Open, 2017, 6 (3):358-364.
[8] Wang J, Xu N, Feng X, et al.Targeted disruption of smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure[J].Cir Res, 2005, 97 (8):821-828.
[9] Picco P, Naselli A, Pala G, et al.Recurrent Pericarditis in Myhre syndrome[J].Am J Med Genet A, 2013, 161 (5):1164-1166.
[10] McGowan R, Gulati R, McHenry P, et al.Clinical features and respiratory complications in Myhre syndrome[J].Eur J Med Genet, 2011.
[11] Whiteford ML, Doig WB, Raine PA, et al.A new case of Myhre syndrome[J].Clin Dysmorphol,2001,10 (2):135-140.
[12] Starr LJ, Grange DK, Delaney JW, et al.Myhre syndrome: clinical features and restrictive cardiopulmonary complications[J].Am J Med Genet A,2015,167 (12):2893-2901.